Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 35 OTHER_GOV 1 NIH 1 FED 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Breast Neoplasms 2 Syndrome 1 Salivary Gland Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Disease 1 Depression 1 Colorectal Neoplasms 1 Chronic Pain 1 COVID-19 1 Anxiety Disorders 1 Acute Pain 1

Interventions

Irinotecan 11 Oxaliplatin 8 Cetuximab 7 Fluorouracil 6 Leucovorin 5 Bevacizumab 5 Standard of Care 4 S 1 (combination) 4 Capecitabine 4 trifluridine tipiracil drug combination 2 tislelizumab 2 apatinib 2 Propranolol 2 Preoperative Exercise 2 Panitumumab 2 Levoleucovorin 2 Folfox protocol 2 Etodolac 2 Endoscopic Mucosal Resection 2 Drug Therapy 2 Chemotherapy, Adjuvant 2 trebananib 1 regorafenib 1 envafolimab 1 Trifluridine 1 Thalidomide 1 Surveys and Questionnaires 1 Occult Blood 1 Neoadjuvant Therapy 1 Moxibustion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Colorectal Neoplasms × Surveys and Questionnaires × Clear all

NCT02804802 2016-06-24

IDYLIC

University Hospital, Angers

49,000 enrolled

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡